Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Weichselbaum

Showing results (581-590 of 727) with videos related to

Pageof 73
Sort By:
Nature Biomedical Engineering|April 25, 2019
Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapyKuangda Lu, Chunbai He, Nining Guo, et al.
Cellular & Molecular Immunology|June 6, 2017
Type 3 innate lymphoid cell-derived lymphotoxin prevents microbiota-dependent inflammationYuan Zhang, Tae-Jin Kim, Joanna A Wroblewska, et al.
Scientific Reports|March 12, 2021
CDK1 is up-regulated by temozolomide in an NF-κB dependent manner in glioblastomaDavid J Voce, Giovanna M Bernal, Kirk E Cahill, et al.
Molecular Cell|December 14, 2011
p50 (NF-κB1) is an effector protein in the cytotoxic response to DNA methylation damageAdam M Schmitt, Clayton D Crawley, Shijune Kang, et al.
Cancer|January 1, 1989
A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancerE E Vokes, R L Schilsky, K E Choi, et al.
Oncogene|February 10, 2015
MUC1-C activates the TAK1 inflammatory pathway in colon cancerH Takahashi, C Jin, H Rajabi, et al.
Nature Medicine|August 1, 1995
Spatial and temporal control of gene therapy using ionizing radiationD E Hallahan, H J Mauceri, L P Seung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancerTanguy Y Seiwert, Daniel J Haraf, Ezra E W Cohen, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1990
Radiobiological characterization of head and neck and sarcoma cells derived from patients prior to radiotherapyR R Weichselbaum, M A Beckett, S Vijayakumar, et al.
Journal of the National Cancer Institute|November 16, 2019
Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare AnalysisStanley L Liauw, Sandra A Ham, Lauren C Das, et al.
Pageof 73

Showing results (581-590 of 727) with videos related to

Sort By:
Pageof 73
Nature Biomedical Engineering|April 25, 2019
Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapyKuangda Lu, Chunbai He, Nining Guo, et al.
Cellular & Molecular Immunology|June 6, 2017
Type 3 innate lymphoid cell-derived lymphotoxin prevents microbiota-dependent inflammationYuan Zhang, Tae-Jin Kim, Joanna A Wroblewska, et al.
Scientific Reports|March 12, 2021
CDK1 is up-regulated by temozolomide in an NF-κB dependent manner in glioblastomaDavid J Voce, Giovanna M Bernal, Kirk E Cahill, et al.
Molecular Cell|December 14, 2011
p50 (NF-κB1) is an effector protein in the cytotoxic response to DNA methylation damageAdam M Schmitt, Clayton D Crawley, Shijune Kang, et al.
Cancer|January 1, 1989
A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancerE E Vokes, R L Schilsky, K E Choi, et al.
Oncogene|February 10, 2015
MUC1-C activates the TAK1 inflammatory pathway in colon cancerH Takahashi, C Jin, H Rajabi, et al.
Nature Medicine|August 1, 1995
Spatial and temporal control of gene therapy using ionizing radiationD E Hallahan, H J Mauceri, L P Seung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancerTanguy Y Seiwert, Daniel J Haraf, Ezra E W Cohen, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1990
Radiobiological characterization of head and neck and sarcoma cells derived from patients prior to radiotherapyR R Weichselbaum, M A Beckett, S Vijayakumar, et al.
Journal of the National Cancer Institute|November 16, 2019
Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare AnalysisStanley L Liauw, Sandra A Ham, Lauren C Das, et al.
Pageof 73